Výsledky vyhledávání - Yuko Ishii
- Zobrazuji výsledky 1 - 7 z 7
-
1
Embryonic Birthdate of Hypothalamic Leptin-Activated Neurons in Mice Autor Yuko Ishii, Sébastien G. Bouret
Vydáno 2012Artigo -
2
-
3
Clinical Validation of <i>PBRM1</i> Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma Autor David A. Braun, Yuko Ishii, Alice M. Walsh, Eliezer M. Van Allen, Catherine J. Wu, Sachet A. Shukla, Toni K. Choueiri
Vydáno 2019Artigo -
4
Identification of Genes Upregulated in <i>ALK</i>-Positive and <i>EGFR/KRAS/ALK</i>-Negative Lung Adenocarcinomas Autor Hirokazu Okayama, Takashi Kohno, Yuko Ishii, Yoko Shimada, Kouya Shiraishi, Reika Iwakawa, Koh Furuta, Koji Tsuta, Tatsuhiro Shibata, Seiichiro Yamamoto, Shun‐ichi Watanabe, Hiromi Sakamoto, Kensuke Kumamoto, Seiichi Takenoshita, Noriko Gotoh, Hideaki Mizuno, Akinori Sarai, Shuichi Kawano, Rui Yamaguchi, Satoru Miyano, Jun Yokota
Vydáno 2011Artigo -
5
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial Autor Jean‐Christophe Pignon, Opeyemi A. Jegede, Sachet A. Shukla, David A. Braun, Christine E. Horak, Megan Wind‐Rotolo, Yuko Ishii, Paul J. Catalano, Jonian Grosha, Abdallah Flaifel, Jesse Novak, Kathleen M. Mahoney, Gordon J. Freeman, Arlene H. Sharpe, F. Stephen Hodi, Robert J. Motzer, Toni K. Choueiri, Catherine J. Wu, Michael B. Atkins, David F. McDermott, Sabina Signoretti
Vydáno 2019Artigo -
6
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma Autor Nizar M. Tannir, Sabina Signoretti, Toni K. Choueiri, David F. McDermott, Robert J. Motzer, Abdallah Flaifel, Jean‐Christophe Pignon, Miriam Ficial, Osvaldo Arén Frontera, Saby George, Thomas Powles, Frede Donskov, Michael R. Harrison, Philippe Barthélémy, Scott S. Tykodi, Judit Kocsis, Alain Ravaud, Jerónimo Rafael Rodríguez‐Cid, Sumanta K. Pal, André M. Murad, Yuko Ishii, Shruti Shally Saggi, M. Brent McHenry, Brian I. Rini
Vydáno 2020Carta -
7
Data from Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma Autor Nizar M. Tannir, Sabina Signoretti, Toni K. Choueiri, David F. McDermott, Robert J. Motzer, Abdallah Flaifel, Jean‐Christophe Pignon, Miriam Ficial, Osvaldo Arén Frontera, Saby George, Thomas Powles, Frede Donskov, Michael R. Harrison, Philippe Barthélémy, Scott S. Tykodi, Judit Kocsis, Alain Ravaud, Jerónimo Rafael Rodríguez‐Cid, Sumanta K. Pal, André M. Murad, Yuko Ishii, Shruti Shally Saggi, M. Brent McHenry, Brian I. Rini
Vydáno 2023Pré-impressão
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Oncology
Immunotherapy
Nivolumab
Renal cell carcinoma
Cancer
Arcuate nucleus
Biology
Cancer research
Carcinoma
Clear cell renal cell carcinoma
Clinical trial
Endocrinology
Gene
Hypothalamus
Immune system
Immunology
Ipilimumab
Neuroscience
Phases of clinical research
Response Evaluation Criteria in Solid Tumors
Sunitinib
Adenocarcinoma
Anaplastic lymphoma kinase
Apoptosis
Autophagy
Axon
Biochemistry
CD8